Sign in

CIK 0001438533

  • Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
262383102
Phone
+1 888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,495,607
in 10 filings, $79.5M under 10b5-1 plans

Net −$79,495,607. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-02-12 ASELAGE STEVE Chief Executive Officer Sale −1,065 $21.50 $23K 257,642
2019-02-11 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −885 $21.38 $19K 15,442
2019-02-11 ROTE WILLIAM E. Senior Vice President, R&D Sale −993 $21.38 $21K 16,999
2019-02-11 Clague Laura Chief Financial Officer Sale −1,017 $21.38 $22K 11,016
2019-02-11 ASELAGE STEVE Chief Executive Officer Sale −1,065 $21.38 $23K 258,707
2019-01-09 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −750 $23.82 $18K 16,327
2019-01-08 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −750 $24.09 $18K 17,077
2019-01-04 Dube Eric M Chief Executive Officer Grant or award +50,000 50,000
2019-01-04 Dube Eric M Chief Executive Officer Grant or award · Employee stock option (right to buy) +400,000 400,000
2019-01-04 Dube Eric M Chief Executive Officer Grant or award · Performance-based restricted stock units +50,000 50,000
2018-12-21 ASELAGE STEVE Chief Executive Officer Sale −5,288 $21.69 $115K 260,672
2018-12-21 ASELAGE STEVE Chief Executive Officer Sale −900 $22.35 $20K 259,772
2018-12-21 Clague Laura Chief Financial Officer Sale −2,850 $21.67 $62K 12,933
2018-12-21 Clague Laura Chief Financial Officer Sale −900 $22.34 $20K 12,033
2018-12-20 McFarlane Neil F. Chief Operating Officer Sale −4,721 $22.00 $104K 35,360
2018-12-20 McFarlane Neil F. Chief Operating Officer Sale −6,404 $22.56 $144K 28,956
2018-12-20 ASELAGE STEVE Chief Executive Officer Sale −6,188 $21.97 $136K 265,960
2018-12-20 Clague Laura Chief Financial Officer Sale −3,750 $22.08 $83K 15,783
2018-12-18 Clague Laura Chief Financial Officer Grant or award +7,500 19,533
2018-12-18 McFarlane Neil F. Chief Operating Officer Grant or award +11,125 40,081

Page 48 of 51 · 1,020 trades